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Psoralen photophysics has been studied on quantum chemistry grounds using the
multiconfigurational second-order perturbation method CASPT2. Absorption and emission spectra
of the system have been rationalized by computing the energies and properties of the low-lying
singlet and triplet excited states. The S1 * state has been determined to be responsible of the
lowest absorption and fluorescence bands and to initially carry the population in the photophysical
processes related to the phototherapeutic properties of psoralen derivatives. The low-lying T1 *
state is, on the other hand, protagonist of the phosphorescence, and its prevalent role in the reactivity
of psoralen is suggested to be related to the elongation of the pyrone ring C3–C4 bond, where the
spin density is distributed on both carbon atoms. Analysis of energy gaps and spin-orbit coupling
elements indicates that the efficient photophysical process leading to the population of the lowest
triplet state does not take place at the Franck-Condon region but along the S1 relaxation path.
© 2006 American Institute of Physics. DOI: 10.1063/1.2178794I. INTRODUCTION
Absorption of electromagnetic radiation by a chro-
mophore triggers a chain of photochemical reactions which
may be beneficially employed to treat some skin disorders
and other diseases. Sometimes the chromophore is already
present in the tissue and the phototherapy takes place natu-
rally, e.g., the cure of neonatal hyperbilirubinemia or the
photoregeneration of vitamin D.1 However, in the treatment
named photochemotherapy, a drug is administered to act as a
photosensitizer, a substance which is harmless in the dark but
active upon absorption of radiation, typically ultraviolet, vis-
ible, or near infrared light.1 Two basic photochemical mecha-
nisms are responsible for the phototherapeutical activity. The
photosensitizer can directly react with DNA bases forming
stable adducts which interfere the genetic activity.1–5 On the
other hand, the photosensitizer can transfer its excess energy
to molecular oxygen available in the cellular environment,
generating highly reactive singlet oxygen able to damage
target tissues. This type of protocol is known as photody-
namic therapy PDT.1,6,7
A generally accepted classification of the photochemo-
therapeutic reactions comprises three types of mechanisms.
Types I and II correspond to oxygen-dependent pathways for
PDT activity, taking place when light, in the presence of a
photosensitizer and molecular oxygen, induces a chemical
reaction in a substrate.1,6,8,9 In type I reactions, the photoac-
tive compound in its triplet state promotes an electron trans-
fer reaction to molecular oxygen, leading to the formation of
O2·, OH·, or HO2· radicals. Type II reactions correspond to
energy transfers from the triplet state of the photosensitizer
to dioxygen, generating the reactive 1g excited state.
10 All
these intermediate species later interact with components of
the cell membrane leading to cellular damage that eventually
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DNA repair, and carcinogenesis.1,8,11,12 In contrast to the pre-
vious mechanisms, oxygen-independent type III reactions
lead to direct photobinding between the photosensitizer and
the DNA base monomers.13–15
Furocoumarins also named psoralens are a class of het-
erocyclic compounds with a known phototherapeutic activity
involving the three described mechanisms.16 These systems
have been found to possess mutagenic properties when ap-
plied in conjunction with near UV-A light 320–400 nm
exposure.17,18 A specific treatment coined psoralen+UV-A
PUVA therapy has been designed to treat different skin
disorders such as psoriasis and vitiligo.1,19,20 It is commonly
assumed that the mechanism of PUVA therapy involves a
2+2-photocycloaddition of psoralen in its lowest triplet
state and a pyrimidine DNA base monomer that requires the
transfer of hydrogen atoms or electrons without direct in-
volvement of molecular oxygen. The photoreactive process
seems to take place in three phases. The first step occurs in
the dark: The furocoumarin is inserted between adjacent py-
rimidine base pairs in the DNA duplex. In a second step, the
absorption of one photon by psoralen induces the formation
of monoadducts with the neighboring pyrimidine via interac-
tion of the respective carbon-carbon double bonds that both
compounds have. Two types of monoadducts, pyrone and
furan types, can then be formed by interaction of the C–C
double bond of the pyrimidine base with the C3–C4 double
bond of the pyrone ring and the C4–C5 double bond of the
furan ring in psoralens, respectively see Fig. 1. In that re-
gard, thymine has been established as the most favorable
base to photoreact with furocoumarins, in accordance with
its predominance in the formation of cyclobutane dimers
TT in UV-irradiated DNA.21,22 In a third step, the
monoadduct may absorb another photon, inducing its other
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the opposite strand of DNA. Therefore, a diadduct that cross-
links the DNA helix is formed.
The polydA-dT·polydA-dT sequence region seems to
be the most favorable site for the photocycloaddition reac-
tions of furocoumarins.23 Several studies have suggested
that, whereas the furan monoadduct forms a diadduct, the
pyrone monoadduct does not.3,5,24 Formation of cross-links
was thought to be extremely relevant for the therapeutic ef-
fectiveness, although it is also known that the diadduct
causes adverse side effects such as carcinogenesis, mutagen-
esis, and immunosuppression difficult to repair.3,8 Only furo-
coumarins with bifunctional groups such as psoralen can
form diadducts and may produce undesired lethal and mu-
tagenic consequences. Certain monofunctional furocou-
marins have been proved to yield as efficient phototherapy as
bifunctional furocoumarins, suggesting that the induction of
lesions in DNA cannot be considered as the only mechanism
responsible for the phototherapeutic effects5 and most prob-
ably a PDT process also takes place. The detailed character-
ization of the mechanisms is still under intense research.
Understanding the photophysical properties of furocou-
marins represents a crucial step in order to rationalize the
corresponding phototherapeutic mechanisms. The low-lying
region of the absorption spectrum of psoralen, the reference
compound, has two main bands: A weak and structured band
is observed ranging from 360 to 270 nm 3.44–4.77 eV and
a sharp feature appears at 240 nm 5.16 eV in aqueous so-
lution and ethanol.25,26 Both fluorescence and phosphores-
cence emissions have been detected for psoralen in ethanol
77 K at 409 nm 3.03 eV and 456 nm 2.72 eV,T0, re-
spectively. The phosphorescence/fluorescence quantum yield
ratio, 7.1, indicates the effectiveness of an intersystem cross-
ing ISC mechanism.27 It has been proposed that photoreac-
tivity of furocoumarins proceeds through the triplet state in
all types of photosensitization, that is, PDT and PUVA
therapies.5 It can be therefore expected that increasing of the
triplet formation quantum yield leads to an enhancement of
FIG. 1. Psoralen molecule atom labeling bottom and ground state opti-
mized bond lengths in angstroms top. The arrow defines the positive
angles of both the dipole moment and electronic transition moment direc-
tions with respect to the pseudosymmetry long axis.the phototherapeutic action.
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sensitizer should possess, in principle, certain desirable key
features: it must be harmless in the dark; in order to treat
deep tissues, it should be activated by long wavelength light,
because the longer wavelength radiation the photosensitizer
absorbs, the deeper the energy penetrates in the body; its
triplet state must be efficiently populated from the excited
singlet state and effective in transferring the energy to mo-
lecular oxygen in the PDT mechanism; and finally, it should
form monoadducts and perhaps not diadducts with DNA to
avoid mutagenic side effects. Additionally, a good photosen-
sitizer should be amphiphilic to favor the injected adminis-
tration of the drug, easily synthesized or isolated from natu-
ral sources, be deactivated soon after the treatment, and
quickly eliminated from the body.1
We are currently undertaken a project to study, using
quantum-chemical methods, the photophysics and photo-
chemistry of furocoumarins and related compounds in order
to rationalize the basic features responsible of their photo-
therapeutic properties. In the present paper we start by con-
sidering the photophysical properties of parent psoralen 7-
H-furo3,2-g1-benzopyran-2-one, see Fig. 1. The low-
lying excited states of the molecule have been computed
within the framework of multiconfigurational second-order
perturbation theory, in particular, with the CASPT2 method.
Absorption, fluorescence, and phosphorescence spectra have
been characterized, together with other spectroscopic param-
eters required to understand the photophysics of the com-
pound: related oscillator strengths, dipole moments, emission
radiative lifetimes, and spin-orbit couplings. Knowledge on
theoretical grounds about these properties in psoralen shall
hopefully guide future research on the photochemical mecha-
nisms of phototherapeutical activity of furocoumarins and
derivatives. In the light of the present results, previous
experimental23,25–28 and theoretical13,29–32 findings shall also
be considered.
II. COMPUTATIONAL DETAILS
Using the CASSCF multiconfigurational wave functions
as reference, the second-order perturbation theory through
the CASPT2 method was employed to include dynamic cor-
relation energy in the calculation of the electronic excited
states. The CASPT2 method calculates the first-order wave
function and the energy up to second order and has repeat-
edly proved its accuracy.33–37 The imaginary level-shift tech-
nique was employed in order to prevent the effect of intruder
states. A shift parameter of 0.3 a.u. was selected by checking
the stability in the excitation energies.38,39 The molecular
symmetry was constrained to the Cs point group. For geom-
etry optimizations, however, relaxing the symmetry con-
straints had no effect on the final structure, which preferred
in all cases to maintain planarity. An atomic natural orbital
ANO-L-type basis set contracted to C,O4s3p1d /
H2s1p Refs. 40 and 41 was used throughout except in the
calculation of the lowest-lying Rydberg state, for which the
basis set was enlarged with an additional s diffuse function
placed in the charge centroid of the cation and built as re-
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trons were kept frozen in the second-order perturbation step.
Geometries were obtained by computing analytical gra-
dients at the RASSCF level of calculation for the ground and
the lowest singlet and triplet excited states. In the optimiza-
tion of the A states an active space of 14 active orbitals and
16 electrons has been employed and up to quadruple excita-
tions were considered eight orbitals in RAS1 space and six
orbitals in RAS3 space. Within the irreducible representa-
tions a ,a of the Cs group this active space can be labeled
as 0,14. An additional oxygen lone-pair orbital was in-
cluded in the active space 1,14 in order to optimize the
lowest A excited states. In all the remaining calculations,
CASSCF wave functions were generated as state-average
SA CASSCF roots of a given symmetry. Based on prelimi-
nary RASSCF calculations, the CASSCF active space was
reduced to include 12 active electrons and 12 active orbitals
RAS2 0,12 for A roots and 14 active electrons and 13
active orbitals RAS2 1,12 for A roots. The number of se-
lected SA-CASSCF roots were 11, 4, 7, and 3 for 1A, 1A,
3A, and 3A symmetries, respectively. The CAS state inter-
action method43 CASSI was used to compute transition
properties, including the spin-orbit coupling SOC elements
between selected states as described elsewhere.44 All calcu-
lations in the present paper were performed with the
MOLCAS-6.0 quantum chemistry software.45,46
III. RESULTS AND DISCUSSION
A. Absorption spectrum
Our final goal is to understand the photophysical prop-
erties of psoralen in order to relate the obtained information
to its biological activity. We first start by studying the
singlet-singlet and singlet-triplet spectra of the molecule.
Several singlet excited states have been computed vertically
at the S0 1 1A ground state optimized RASSCF structure.
The results are compiled in Table I. Hereafter only CASPT2
results will be discussed. The lowest singlet excited state,
2 1A*, lies vertically at 3.98 eV with a related oscilla-
tor strength of 0.027. Next, the 1 1An* state is found at
5.01 eV corresponding to a transition predicted with negli-
gible intensity. A third transition to the 3 1A state has been
computed at 5.03 eV with an oscillator strength of 0.107.
Unlike the other * states, the 3 1A state has a high dipole
moment, 8.72 D, differing by more than 2.5 D from that of
the ground state, an indication of its sensitivity to polar en-
vironments, in which the related transition is expected to
undergo a redshift. The recorded absorption spectra in differ-
ent solvents, from cyclohexane47 to water,26 displays a weak
and structured band ranging from 360 to 270 nm
3.44–4.77 eV. Depending on the band resolution and the
environment, one or two maxima near 330 and 280 nm 3.76
and 4.43 eV, respectively have been described. The present
computed results suggest that this set of features can be bet-
ter assigned just to the 2 1A* transition, with the weak
n* band lying beneath. In that case, the observed band pro-
file should be attributed to vibrational structure. This is not
unlikely, considering that a noticeable rearrangement of the
1bond distances of the molecule occurs at the 2 A minimum.
Downloaded 29 Jan 2010 to 147.156.182.23. Redistribution subject toFurthermore, the structure of the band disappears in different
media and also in all psoralen derivatives, even in selenopy-
rane and thyopyrane psoralen derivatives.26 Calculations at
the time-dependent density-functional theory13,48 TD-DFT
and DFT/multireference configuration interaction32 MRCI
levels of theory suggest, however, that two *-type transi-
tions computed near 3.8 and 4.4 eV are really responsible of
the low-energy band. A definitive assignment would require
a full analysis of the vibrational structure of the band and
comparison with spectra in the vapor or in molecular beams.
Above 5.0 eV several singlet-singlet transitions have
also been computed. Transitions to the 4 1A 5.22 eV and
5 1A 5.30 eV * excited states have oscillator
strengths of 0.064 and 0.331, respectively. The recorded
spectra show a single and sharp band peaking near 248 nm
5.00 eV in cyclohexane47 and 240 nm 5.16 eV in ethanol
and water.25,26 In principle, the observed feature can be as-
signed to transition to the 3 1A state at 5.03 eV. Moreover,
taking into account our computed results, an additional band
with higher intensity can be expected at higher energies
5.30 eV. The measured band is probably a combination of
both transitions. Between 5.7 and 6.2 eV four medium to
intense transitions to 1A * excited states are predicted.
Above this energy only weak transitions of valence * and
n* character have been obtained up to 8.0 eV. The begin-
ning of the Rydberg series has been determined at 6.32 eV,
as the 2 1A highest occupied molecular orbital HOMO
→3s state. Two intense bands peaking at 210 nm 5.90 eV
and 200 nm 6.20 eV have been reported for psoralen in
1,1,1,3,3,3-hexafluoro-2-propanol.47 They clearly correspond
to the transitions to our computed 7 1A and 8 1A *
states, representing the most intense bands in that energy
region of the spectrum. Song et al.25 reported that the two
TABLE I. Computed excitation energies E eV, oscillator strengths f ,
dipole moments  D, and dipole moment, dir deg, and transition dipole
moment, TDMdir deg, directions for the low-lying electronic transitions of
psoralen.
State ECASSCF ECASPT2 f  dir TDMdir
1 1A ¯ ¯ 6.25 128 ¯
2 1A* 4.52 3.98 0.027 6.50 132 4
1 1An* 4.22 5.01 0.000 2.07 130 ¯
3 1A* 6.33 5.03 0.107 8.72 132 5
4 1A* 6.68 5.22 0.064 7.07 −23 −10
5 1A* 6.73 5.30 0.331 7.07 −37 102
6 1A* 6.95 5.70 0.091 7.37 −37 30
7 1A* 7.21 5.81 0.321 6.58 −34 127
8 1A* 7.30 6.17 0.287 6.56 −42 4
9 1A* 7.57 6.24 0.168 4.25 −35 −7
10 1A* 7.72 6.28 0.012 6.29 −40 −7
2 1An* 6.39 6.32 0.000 0.11 43 ¯
1 3A* 2.57 3.27 ¯ 5.40 124 ¯
2 3A* 3.13 3.55 ¯ 5.35 125 ¯
3 3A* 3.82 4.08 ¯ 5.48 127 ¯
4 3A* 4.18 4.66 ¯ 5.97 129 ¯
5 3A* 4.43 4.67 ¯ 5.41 124 ¯
6 3A* 5.68 4.84 ¯ 6.78 −31 ¯
1 3An* 4.07 4.85 ¯ 2.15 111 ¯lowest-energy absorption bands in psoralen, angelicin, and
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parallel, with angles differing less than 20°. Transition dipole
moment TDM directions indicate that the three lowest *
features have nearly parallel polarizations, that is, they are
aligned with the long axis of the molecule, while transition to
the 5 1A state has essentially perpendicular polarization.
Regarding the vertical excitations to the triplet states, the
1 3A * T1 state lies at 3.27 eV, near 0.7 eV below the
2 1A S1 state. Three other 3A * states are next in en-
ergy at 3.55, 4.08, and 4.66 eV. The lowest triplet state of
n* character, 3A, has been located vertically at 4.85 eV,
slightly below with respect to its corresponding singlet state.
TD-DFT Ref. 13 and DFT/MRCI Ref. 32 results obtained
similar results for the location of the triplet states, although,
as it is typical for DFT-based methods,49 singlet-triplet tran-
sitions are underestimated 0.2–0.3 eV.
The nature of the low-lying transitions of each symme-
try, which are those basically responsible for the photophysi-
cal properties of psoralen, can be graphically described by
computing the differential electron density plots as displayed
in Fig. 2. Transition to the S1 * state is mainly benzene-
like, with the charge migration concentrated in the central
benzenoid ring. On the contrary, that related to the T1 *
state has its major contributions in the pyrone ring, with high
participation of the carbonyl oxygen and a shift in the den-
sity away from the pyrone ring C3–C4 bond, which will be
later discussed as an essential feature of the photophysics of
the system. Also in Fig. 2, we find the expected differential
density plots of the n* states focused on the carbonyl group.
B. Emission spectra
Fluorescence has been reported for psoralen in polar sol-
vents starting T0 at 350 nm 3.54 eV with a maximum at
409 nm 3.03 eV.27,28 Phosphorescence has also been re-
corded in solution with band origin at 456 nm 2.72 eV and
a maximum between 460 and 490 nm 2.7–2.5 eV. Psor-
alens are characterized by a weak fluorescence emission and
strong phosphorescence bands. In particular, in psoralen, the
fluorescence quantum yield was measured in ethanol, F
28
FIG. 2. Differential electron density for the main valence transitions in
psoralen computed at the ground state optimized geometry. The electron
density is shifted upon light-induced excitation from darker to lighter
regions.=0.019 Refs. 27 and 0.02, while the phosphorescence
Downloaded 29 Jan 2010 to 147.156.182.23. Redistribution subject toquantum yield was reported to be P=0.13.27 The obtained
ratio P /F is approximately 7.1. The total phosphores-
cence decay time P has been established in glycerol-water
as 1.1 s Ref. 28 and in ethanol as 0.66 s.27 The phospho-
rescence radiative lifetime can be therefore obtained as rad
=PP from 8 to 5 s.
Our computed results on Table II allow the rationaliza-
tion of part of the experimental data. The low-lying singlet
excited 2 1A* state is responsible for the lowest-energy
absorption and emission fluorescence bands. Vertically, at the
ground state geometry, the transition energy is computed to
be 3.98 eV and, upon relaxation of the geometry, the band
origin Te obtained as the energy difference between the
ground and the excited state minima decreases to 3.59 eV. A
similar relaxation is observed experimentally between the
lowest-energy reported absorption band maximum and the
band origin. The computed changes in the optimal geom-
etries between the ground S0 and the 2 1A* S1 states
affect the bond alternation of the system, mainly in the cen-
tral ring cf. Figs. 1 and 3, as expected from the discussion
on the differential charge density plots of Fig. 2. By using the
Strickler-Berg relationship,36,50,51 a fluorescence radiative
lifetime of 74 ns is calculated for the S1 state. The low-lying
TABLE II. Computed and experimental energy differences eV and emis-
sion radiative lifetimes rad relevant for the photophysics of psoralen. EVA:
vertical absorption, Te: adiabatic electronic band origin, EVE: vertical emis-
sion, Absmax: experimental absorption maximum, T0: experimental band ori-
gin, and Emax: emission maximum.
State
Theoretical CASPT2 Experimentala
EVA Te EVE rad Absmax T0 Emax rad
2 1A* 3.98 3.59 3.45 74 ns 3.7–4.3 3.54 3.03 ¯
1 1An* 5.01 3.91 2.78 3 s ¯ ¯ ¯ ¯
1 3A* 3.27 2.76 2.29 28 s ¯ 2.7 2.7 5–8 s
1 3An* 4.85 3.84 2.79 9 ms ¯ ¯ ¯ ¯
aData in ethanol Refs. 25–28 and 55. See also other solvents Ref. 47.
FIG. 3. Psoralen molecule optimized bond lengths Å in different elec-
1 * 1 *tronic singlet states. Top: 2 AS1 , ; bottom: 1 AS2 ,n .
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by more than 1 eV upon geometry optimization. The main
variations are obtained in the pyrone ring up to −0.13 Å
and in the CvO bond length 0.16 Å. Although the
1 1An* minimum belongs to the S1 hypersurface, the fi-
nal Te value is near 0.3 eV higher in energy than the com-
puted and measured band origin for 2 1A*. Therefore
the n* state it is not a plausible candidate for the fluores-
cence, which is better attributed to the * state. To support
the assignment we cannot rely on the dependence of the re-
corded fluorescence emission on the solvent polarity, which
is not clear in psoralen. Nevertheless, it is possible to support
the assignment by comparing intrinsic fluorescence lifetimes.
In principle, no experimental lifetimes have been reported,
but from our computed radiative lifetimes, 74 ns for
2 1A* and 3 s for 1 1An*, and the experimental
fluorescence quantum yield 0.016,27 they can be deduced as
1.2 and 72 ns, respectively. Taking into account that the re-
ported measurements were performed at time resolutions not
lower than 2 ns,27 the lack of measured lifetimes points out
to a preferred assignment to the * S1 state, with a faster
fluorescence decay. Certainly, studies at a higher time reso-
lution would be desirable.
The 1 3A* state is clearly protagonist of the phos-
phorescence. A band origin computed at 2.76 eV perfectly
relates to the observed value in solution at 2.72 eV.27 The
change in geometry calculated from the ground state mini-
mum is here more pronounced, in particular, at the pyrone
ring, while the relaxation in energy reaches nearly 0.5 eV
cf. Fig. 4. The largest structural change is computed for the
C3–C4 bond of the pyrone ring, which enlarges upon absorp-
tion and further relaxation by near 0.13 Å. The computed
spin population, displayed in Fig. 5, is mainly placed on each
of the carbon atoms forming the bond. In that way, psoralen
becomes highly reactive in its lowest triplet state through its
pyrone C3–C4 bond. This finding is the cornerstone of the
FIG. 4. Psoralen molecule optimized bond lengths Å in different elec-
tronic triplet states. Top: 1 3AT1 ,*; bottom: 1 3AT7 ,n*.photophysics of psoralen, which has been repeatedly pro-
Downloaded 29 Jan 2010 to 147.156.182.23. Redistribution subject toposed to take place through a reactive triplet state, and it is
also in agreement with the structure proposed for the phos-
phorescence band, mainly based on the intense vibrational
progression corresponding to a CvC stretching mode in the
pyrone moiety.27 The computed phosphorescence radiative
lifetime is 28 s, slightly higher than those estimated experi-
mentally from the quantum yield and the total relaxation
time, 5 and 8 s.27,28 For the 2 3A* state the spin popu-
lation is placed mainly on the carbon atoms forming both
CvC bonds, that is, C3–C4 pyrone and C4–C5 furan.
C. Photophysics of psoralen
Since the phototherapeutic properties of psoralen initiate
by irradiation with light of wavelengths of 320–400 nm
3.87–3.10 eV, the only state which will be significantly
populated by direct absorption is the spectroscopic
2 1A*S1 singlet state. The excited molecule will evolve
towards the minimum of S1, from which fluorescence will
take place. The recorded phosphorescence/fluorescence
emission ratio of 7.1 Ref. 27 emphasizes the role of the
triplet states in the photophysics of the system. That is, the
lowest-lying triplet 1 3A*T1 must be populated, either
by direct absorption or by means of an effective intersystem
crossing mechanism. T1 state lies much lower in energy than
the S1 state, both vertically 0.6 eV and adiabatically
1.2 eV. The occurrence of direct interaction between
both vertical states is unlikely, and therefore another mecha-
nism has to be found, involving probably population of
higher-lying triplet states continued by internal conversions
towards T1. In order to populate a triplet state by direct ab-
sorption, the spin-orbit coupling between the initial ground
state and any of the low-lying triplet states should be quite
large. The qualitative El-Sayed rules52 indicate that the spin-
orbit coupling is maximum between states of * and n*
types and minimum between states of the same nature. The
spin-orbit matrix element between the ground S0 and the
low-lying 1 3An* state is computed to be 47 cm−1, a
large value that leads to a small combined oscillator strength
of 510−6 for the corresponding spin-forbidden transition.
The high phosphorescence quantum yield requires, however,
a much more efficient procedure to populate T1, and there-
FIG. 5. Spin density for the low-lying triplet states in psoralen computed at
the ground state optimized geometry.fore an intersystem crossing ISC must be involved in the
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fective ISC to take place: low energy gap and high spin-orbit
coupling between a singlet and a triplet state. If the initially
populated state is 2 1A*S1, the nonradiative decay to a
triplet state must occur along the relaxation pathway of S1,
starting from the Franck-Condon region ground state geom-
etry, and in close vicinities of a singlet-triplet crossing. Ana-
lyzing the vertical energy differences between the S1 and the
triplet states, the gaps are quite large, while the spin-orbit
coupling SOC elements are small. For instance, the largest
SOC, 3 cm−1, occurs between 2 1A*, that is, S1, and
1 3An*, vertically T7, which are separated by 0.87 eV. A
similar value of 10 cm−1 was obtained at the DFT/MRCI
level.32 Other gaps and couplings studied at the Franck-
Condon region are of minor importance. In order to fully
understand the intersystem crossing mechanism responsible
for the population of the reactive T1 state in psoralen, the
relaxation pathways of the energy should be computed,
searching for regions with near degeneracies or crossings
between the S1 and triplet states having also large SOCs.
These studies are the object of our future research.
IV. SUMMARY AND CONCLUSIONS
In the present research the photophysics of psoralen has
been studied using quantum-chemical methods through the
multiconfigurational second-order perturbation procedure
CASPT2, employing high-quality ANO-type one-electron
basis sets. Optimized geometries for the low-lying singlet
and triplet states, energy differences, and state and transition
properties provide us with important information to under-
stand the excited state structure and the absorption and emis-
sion processes taking place upon irradiation of the molecule.
The absorption spectrum of the system has been studied by
computing vertical excitation energies. A low-lying S1 singlet
excited state of * character with a benzenelike nature is
shown to lie at the energies in which the molecule is irradi-
ated in phototherapy. This state is also proven to be respon-
sible of the recorded fluorescence in different media by com-
puting the emission properties and comparing them to the
experimental measurements. Regarding the triplet state struc-
ture, a T1 * state is computed at low energies as respon-
sible for the strong phosphorescence of the system. Analysis
of the energy gaps and spin-orbit couplings at the Franck-
Condon region suggests that the process responsible for the
population of T1 does not take place vertically and most
probably it occurs along the relaxation path on the S1 hyper-
surface. The study of the proper regions for favorable inter-
system crossing requires the calculation of minimum energy
paths and singlet-triplet crossings. On the other hand, the
suggested role of the S2 n*-type state in the mechanism,27
based on the assumption of the traditional proximity effect53
between singlet * and n* states, is unlikely. This type of
reasoning is always based on vertical gaps, while modern
photophysics is based in most of the cases on nonadiabatic
processes along the energy relaxation paths.36,44,54 Finally,
the reactivity of psoralen in its T1 state and the suggested
role of such state in phototherapy are rationalized in terms of
Downloaded 29 Jan 2010 to 147.156.182.23. Redistribution subject tothe computed spin density distributed on the two carbon at-
oms of the pyrone ring C3–C4 bond, which varies from a
double- to a single-type character.
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